1-(2-Chloro-6-fluoro-benzyl)-[1,4]diazepanedihydrochloride, 98.0%, 2.5g

Benzyl 3-hydroxypropanoate, 95.0%, 25g

Silica gel 150, 1 kg

(E)-4,4'-(Diazene-1,2-diyl)diphenol, 97%, 25g

1-(2-Hydroxyethyl)-3-methylimidazolium Bis(trifluoromethanesulfonyl)imide>98.0%(HPLC)(T)25g

4-Ethylphenylacetylene, 98.0%, 100g

(2R,4R)-1-((Benzyloxy)carbonyl)-4-fluoropyrrolidine-2-carboxylic acid, 100mg

ethyl (1s,3r,5s)-2-boc-2-azabicyclo[3.1.0]hexane-3-carboxylate, 95.0%, 2g

N-Boc-4-Piperidinecarboxaldehyde, 97.0%, 500g

(R)-Benzyl (2-amino-1-phenylethyl)carbamate, 95.0%, 1g

Sodium 3-amino-5-chloro-4-methylbenzenesulfonate, 97.0%, 1kg

Bis(1-phenylethyl)sulfane, 97%, 25g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)